SCM
SGNT

Stonepine Capital Management’s SAGENT PHARMACEUTICALS INC COM STK (DE) SGNT Stock Holding History

Stonepine Capital Management’s Portfolio SGNT Stock Details SGNT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2016
Q3 		– Sell
-356,307
Closed -$5.34M – 25
2016
Q2 		$5.34M Buy
356,307
+23,242
+7% +$299K 5.47% 8
2016
Q1 		$4.05M Sell
333,065
-129,759
-28% -$1.82M 4.78% 7
2015
Q4 		$7.36M Buy
+462,824
New +$7.29M 8.63% 5

Stonepine Capital Management's SGNT Position: Q3 2016 in Review

Stonepine Capital Management sold out of SAGENT PHARMACEUTICALS INC COM STK (DE) (SGNT) in Q3 2016, closing a stake of 356,307 shares — an estimated $5.34M sold.

Stonepine Capital Management first reported a position in SGNT in Q4 2015 and held it in 3 quarters. The position peaked at $7.36M in Q4 2015. 0 funds tracked by Wall St. Rank hold SGNT as of Q3 2016.

  • Stonepine Capital Management reported no remaining SAGENT PHARMACEUTICALS INC COM STK (DE) position as of Q3 2016 after selling out during the quarter.
  • Stonepine Capital Management sold 356,307 SAGENT PHARMACEUTICALS INC COM STK (DE) shares in Q3 2016, an estimated $5.34M.
  • Stonepine Capital Management first reported a position in SAGENT PHARMACEUTICALS INC COM STK (DE) in Q4 2015 and held it in 3 quarters.
  • Stonepine Capital Management's SAGENT PHARMACEUTICALS INC COM STK (DE) position peaked at $7.36M in Q4 2015.
  • 0 funds tracked by Wall St. Rank held SAGENT PHARMACEUTICALS INC COM STK (DE) as of Q3 2016.

Based on Stonepine Capital Management's 13F filing for Q3 2016, filed 14 Nov 2016.